Search
Jan 17
Bausch + Lomb's Brent Saunders on the launch of two dry eye therapies and an update on BeautyHealth and Roam
Brent Saunders discusses the launch of MEIBO and XIIDRA, talks about priorities for 2024, and gives the latest on BeautyHealth and Roam.
Sep 8, 2023
Brent Saunders talks about his priorities for growth at Bausch + Lomb
Brent Saunders describes a recent deal Bausch + Lomb has made in dry eye disease and his goal to push further into retinal diseases as well.